Posts Tagged patients

Futurity.org – To treat cystic fibrosis, drug mimics HIV

Tuesday, May 7th, 2013 | Permalink

“While cystic fibrosis patients are our initial target and a very high-priority target, we also could look at infections associated with burns or indwelling medical devices , such as venous catheters. “We could even look to the biodefense realm, in terms of a rapid, handheld nebulizer treatment that soldiers could use in the case of exposure to a bioterrorism agent.” The researchers have taken out several US and international … Follow Futurity. RSS feeds Facebook Twitter …

See the article here:
Futurity.org – To treat cystic fibrosis, drug mimics HIV

Would you Join the "Facebook of Medicine"? – Technology Review

Friday, April 13th, 2012 | Permalink

On the final day of TEDMED2012, Saxon announced everyheartbeat. org , the site where she hopes to engender the “Facebook of medicine.” The site will begin with heartbeats, which smart … She is already part of an ongoing study that is collecting the heart rate data of some 200000 cardiac patients with implanted medical devices . But, of course, she doesn’t see the majority of … of the latest in emerging technologies. Subscribe to the TR Editors’ blog RSS Feed …

Continued here:
Would you Join the "Facebook of Medicine"? – Technology Review

Good News for Medtronic DBS Therapy – Zacks.com

Friday, March 16th, 2012 | Permalink

Leading medical devices player, Medtronic (MDT) has received approval from Health Canada for the use of its Deep Brain Stimulation (“DBS”) therapy in refractory epilepsy patients. This therapy sends controlled electrical …

View post:
Good News for Medtronic DBS Therapy – Zacks.com

Severe sepsis causes almost 10% of cancer deaths; $CTSO

Wednesday, January 18th, 2012 | Permalink

In 2004, Dr. Mark Williams and his colleagues from Eli Lilly & Co. in Indianapolis, and Health Process Management, LLC, Pennsylvania analyzed hospitalizations from 1999 across six US states and discovered that ”severe sepsis is a common, deadly, and costly complication in cancer patients. This complication was associated with nearly a three-fold increase in the time spent in hospital. We estimate that the annual hospital costs for these patients exceed US $3 billion annually.” They discovered that “almost 5% of the cancer patients that were hospitalized in the six states were found to have severe sepsis. When extrapolated to the rest of the USA, this corresponds to around 126,000 cases every year.” Hospitalized cancer patients with severe sepsis were more than five times more likely to die than cancer patients who were not severely septic. 37.8% of patients with cancer and severe sepsis died in the hospital in comparison to just 7.2% of cancer patients without severe sepsis. This corresponds to the death of around 46,700 patients every year. ”Our study demonstrates the devastating complication of severe infections in cancer patients. Improvement in infection control, such as early appropriate antibiotics, in this population could have a significant impact on overall cancer survival,” said Williams. Read the full article on Science Blog and the study on Critical Care .  In addition to using antibiotics and other supportive care measures, another promising approach to fight sepsis is the reduction of “cytokine storm” and the removal of other toxic substances from the blood that can cause multiple organ failure – the leading cause of death in the ICU from sepsis and other critical care illnesses. CytoSorbents Corporation (OTCBB: CTSO) , a critical care-focused therapeutic device company, is working on this type of blood purification technology. The company’s flagship product, CytoSorb, is an extracorporeal cytokine filter that uses biocompatible, highly porous polymer beads to actively remove toxic substances from blood and other bodily fluids. It recently achieved European regulatory approval and can now be sold throughout the European Union (E.U.) under the CE Mark to be used in cases where cytokines are elevated. Read more about CytoSorbents and its blood purification technology . 

See the article here:
Severe sepsis causes almost 10% of cancer deaths; $CTSO

MMWR: Results of the Expanded HIV Testing Initiative — 25 Jurisdictions, United States, 2007–2010

Friday, June 24th, 2011 | Permalink

Approximately 20% of the estimated 1.2 million persons living with human immunodeficiency virus (HIV) infection in the United States at the end of 2008 were not aware of their infection. Testing, diagnosis, medical care, treatment with highly active antiretroviral therapy (HAART), and access to prevention services soon after HIV infection can prevent morbidity and mortality and reduce a person’s risk for transmitting HIV. In 2006, CDC recommended screening patients aged 13–64 years for HIV infection in health-care settings that have a prevalence of undiagnosed HIV infection of ≥0.1%. In October 2007, CDC initiated the Expanded HIV Testing Initiative (ETI), through which it funded 25 health departments to facilitate HIV screening and increase diagnoses of HIV infections and linkage to care among populations disproportionately affected by HIV, especially non-Hispanic blacks. This report describes the results of that effort.

See the original post:
MMWR: Results of the Expanded HIV Testing Initiative — 25 Jurisdictions, United States, 2007–2010